Foundation Sanammad - Net Worth and Insider Trading

Foundation Sanammad Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Foundation Sanammad owns 1 companies in total, including AXIM Biotechnologies Inc (AXIM) .

Click here to see the complete history of Foundation Sanammad’s form 4 insider trades.

Insider Ownership Summary of Foundation Sanammad

Ticker Comapny Transaction Date Type of Owner
AXIM AXIM Biotechnologies Inc 2014-03-21 10 percent owner

Foundation Sanammad Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Foundation Sanammad Ownership Network

Ownership Network List of Foundation Sanammad

No Data

Ownership Network Relation of Foundation Sanammad

Insider Network Chart

Foundation Sanammad Owned Company Details

What does AXIM Biotechnologies Inc do?

Who are the key executives at AXIM Biotechnologies Inc?

Foundation Sanammad is the 10 percent owner of AXIM Biotechnologies Inc. Other key executives at AXIM Biotechnologies Inc include Chief Operating Officer Kurt Phinney , 10 percent owner Catalina Valencia , and 10 percent owner Glycodots, Llc .

AXIM Biotechnologies Inc (AXIM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AXIM Biotechnologies Inc (AXIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AXIM Biotechnologies Inc (AXIM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AXIM Biotechnologies Inc (AXIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AXIM Biotechnologies Inc Insider Transactions

No Available Data

Foundation Sanammad Mailing Address

Above is the net worth, insider trading, and ownership report for Foundation Sanammad. You might contact Foundation Sanammad via mailing address: 18 East 50th Street, 5th Floor, New York Ny 10022.

Discussions on Foundation Sanammad

No discussions yet.